Gloria Reuben is celebrated for her role as Jeanie Boulet on ER—a character who brought visibility and nuance to HIV at a critical time in the mid‑1990s.
“Playing Jeanie Boulet on ER was a turning point in my career—and in television,” said Reuben. “At a time when HIV was still seen as a death sentence, I worked closely with the producers to ensure Jeanie would not die from AIDS. She remains the first and only character on a primetime network drama living with HIV who didn’t. That role helped shift public perception and gave voice to a reality that was just beginning to change thanks to treatment breakthroughs.”
The 2025 celebration is guided by Event Chairs Tom Postilio and Mickey Conlon — celebrated real estate leaders, media personalities, and steadfast allies of TAG. Their close friendship with Reuben and dedication to public health promise to inspire generosity and help TAG reach its $350,000 fundraising goal.
“Each honoree embodies the drive and innovation at the heart of TAG’s mission,” said Mark Harrington, TAG Executive Director. “We’re honored to celebrate their contributions and gather an evening of unity, storytelling, and impact.”
2025 Honorees:
- Gloria Reuben — Actor and activist
- Jeanne Marrazzo, MD, MPH, FACP, FIDSA — Appointed NIAID Director September 2023, celebrated HIV/STI researcher
- Richard Lynn — TAG Board Member, activist, and philanthropist
Event Details
Date: Monday, October 20, 2025
Venue: Angel Orensanz Foundation, 172 Norfolk St, New York, NY
Time: 6:00 – 9:00 p.m.
Tickets: $300 | Sponsorships Available
For info and tickets: www.treatmentactiongroup.org/riaa
Media Information: Gloria Reuben, Jeanne Marrazzo, Rich Lynn, and TAG staff are available for interviews. High-resolution photos and video assets are available. Please contact Dorrit Walsh at [email protected].
About Treatment Action Group (TAG)
Treatment Action Group (TAG) is an independent, activist-driven research and policy think tank committed to ending the epidemics of HIV, tuberculosis (TB), and hepatitis C (HCV). Since 1992, TAG has worked to ensure that scientific advances lead to real-world impact — especially for communities most affected by these diseases. Through rigorous policy analysis, community engagement, and advocacy for health equity and research funding, TAG fights for a future where all people can access lifesaving prevention, diagnostics, and treatment.
Learn more at www.treatmentactiongroup.org.
SOURCE Treatment Action Group
